Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Apr;189(4):1314-8.
doi: 10.1016/j.juro.2012.10.027. Epub 2012 Oct 22.

Pathological features of lymph node metastasis for predicting biochemical recurrence after radical prostatectomy for prostate cancer

Sigrid V Carlsson  1 , Laura J Tafe, Daher C Chade, Daniel D Sjoberg, Niccolo Passoni, Shahrokh F Shariat, James Eastham, Peter T Scardino, Samson W Fine, Karim A Touijer
Affiliations

Pathological features of lymph node metastasis for predicting biochemical recurrence after radical prostatectomy for prostate cancer

Sigrid V Carlsson et al. J Urol. 2013 Apr.

Abstract

Purpose: Subclassification of nodal stage may have prognostic value in men with lymph node metastasis at radical prostatectomy. We explored the role of extranodal extension, size of the largest metastatic lymph node and the largest metastasis, and lymph node density as predictors of biochemical recurrence.

Materials and methods: We reviewed pathological material from 261 patients with node positive prostate cancer. We examined the predictive value when adding the additional pathology findings to a base model including extraprostatic extension, seminal vesicle invasion, radical prostatectomy Gleason score, prostate specific antigen and number of positive lymph nodes using the Cox proportional hazards regression and Harrell concordance index.

Results: The median number of lymph nodes removed was 14 (IQR 9, 20) and the median number of positive lymph nodes was 1 (IQR 1, 2). At a median followup of 4.6 years (IQR 3.2, 6.0) 155 of 261 patients experienced biochemical recurrence. The mean 5-year biochemical recurrence-free survival rate was 39% (95% CI 33-46). Median diameter of the largest metastatic lymph node was 9 mm (IQR 5, 16). On Cox regression radical prostatectomy specimen Gleason score (greater than 7 vs 7 or less), number of positive lymph nodes (3 or greater vs 1 or 2), seminal vesicle invasion and prostate specific antigen were associated with significantly increased risks of biochemical recurrence. On subset analysis metastasis size significantly improved model discrimination (base model Harrell concordance index 0.700 vs 0.655, p = 0.032).

Conclusions: Our study confirms that the number of positive lymph nodes is a predictor of biochemical recurrence in men with node positive disease. The improvement in prognostic value of measuring the metastatic focus warrants further investigation.

PubMed Disclaimer

Figures

Figure 1
Figure 1. BCR-free survival for cohort
5-year BCR-free survival 39% (95% CI 33%, 46%)
See this image and copyright information in PMC

Comment in

  • Editorial comment.
    Daneshmand S. Daneshmand S. J Urol. 2013 Apr;189(4):1318-9. doi: 10.1016/j.juro.2012.10.137. Epub 2013 Jan 17. J Urol. 2013. PMID: 23333612 No abstract available.
  • Editorial comment.
    Karnes RJ, Briganti A. Karnes RJ, et al. J Urol. 2013 Apr;189(4):1319. doi: 10.1016/j.juro.2012.10.138. Epub 2013 Jan 17. J Urol. 2013. PMID: 23333613 No abstract available.

References

    1. Cheng L, Montironi R, Bostwick DG, et al. Staging of prostate cancer. Histopathology. 2012;60:87. - PubMed
    1. Fleischmann A, Schobinger S, Schumacher M, et al. Survival in surgically treated, nodal positive prostate cancer patients is predicted by histopathological characteristics of the primary tumor and its lymph node metastases. Prostate. 2009;69:352. - PubMed
    1. Fleischmann A, Schobinger S, Markwalder R, et al. Prognostic factors in lymph node metastases of prostatic cancer patients: the size of the metastases but not extranodal extension independently predicts survival. Histopathology. 2008;53:468. - PubMed
    1. Briganti A, Karnes JR, Da Pozzo LF, et al. Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy. Eur Urol. 2009;55:261. - PubMed
    1. von Bodman C, Godoy G, Chade DC, et al. Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy. J Urol. 2010;184:143. - PMC - PubMed

Publication types